Preface to the Special Issue “Novel Pharmaconeurogenetic Approaches Arising from Progress in Translational Genetics”

As modern medicine continues to advance with a focus on novel and selective targets, the need for identification and validation of these targets in preclinical and clinical studies is critical. Rec...

[1]  E. Dorsey,et al.  Financing of U.S. Biomedical Research and New Drug Approvals across Therapeutic Areas , 2009, PloS one.

[2]  Steven V. Fox,et al.  Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist , 2011, Journal of neurogenetics.

[3]  Caitlin Smith,et al.  A question of form , 2003, Nature.

[4]  F. Sams-Dodd.  Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[5]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[6]  S. Friend,et al.  A network view of disease and compound screening , 2009, Nature Reviews Drug Discovery.

[7]  R. Hargreaves,et al.  Clinical biomarkers in drug discovery and development , 2003, Nature Reviews Drug Discovery.